Results 51 to 60 of about 733 (138)
Hemotherapy agencies in compliance with hemotherapy legislation
, 2016 Este estudo tem por objetivo discutir a situação de agências transfusionais do estado do Pará, Brasil, e sua relação com a legislação hemoterápica. Os dados foram coletados a partir da aplicação de questionário aos profissionais médicos, bioquímicos, biomédicos atuantes em seis agências transfusionais da hemorrede estadual, nos meses de agosto e ...Bastos, Marineide Sousa, Souza, Mariluce Karla Bomfim de +1 moreopenaire +1 more sourceFrom Hemophilia to Deep Venous Thrombosis Patient Samples: How to Perform an Easy Coagulometer Validation Process According to Available Guidelines
Clinical and Applied Thrombosis/Hemostasis, 2020 Validation protocols for the evaluation of coagulometers are needed to help professionals select the most suitable system for their regular laboratory routines.Silmara Aparecida de Lima Montalvão PhD, Ana Paula Francisco, Bittar Letícia Queiroz da Silva MSc, Stephany Cares Huber PhD, Helder José Aguiari, Maria Carmem Gonçalves Lopes Fernandes, Priscila Soares Elidio, Beatriz de Moraes Martinelli, Isa Macedo Tony MSc, Marina Pereira Colella PhD, Joyce Maria Annichinno-Bizzachi PhD +10 moredoaj +1 more sourceHepatitis C virus and hepatitis B virus in indolent lymphomas: Prospective data from the international observational NF10 study
British Journal of Haematology, Volume 208, Issue 6, Page 2229-2234, June 2026.Luca Arcaini, Michele Merli, Sara Rattotti, Maria Elena Nizzoli, Vittoria Tarantino, Chiara Consoli, Annalisa Talami, Roberta Murru, Marina Deodato, Emanuele Cencini, Francesca Re, Carlo Visco, Guilherme Duffles, Michele Spina, Ombretta Annibali, Alessandro Pulsoni, Andrés J. M. Ferreri, Caterina Stelitano, Elsa Pennese, Marzia Varettoni, Emilia Cappello, Gianmarco Favrin, Martina La Fauci, Luigi Marcheselli, Marco Paulli, Stefano Luminari +25 morewiley +1 more sourceJoint Damage Prediction in Non-Severe Hemophilia A with Artificial Intelligence
Journal of Blood MedicineAna Marco-Rico,1 José Manuel Calvo-Villas,2 Francisco-Jose Lopez-Jaime,3 Mariana Canaro Hirnyk,4 María del Mar Nieto-Hernández,5 Sonia Herrero Martín,6 Laura Entrena-Ureña,7 Shally Marcellini-Antonio,8 Bolivar L Diaz-Jordan,9 Sergio Jurado-Herrera,10 ...Marco-Rico A, Calvo-Villas JM, Lopez-Jaime FJ, Canaro Hirnyk M, Nieto-Hernández MDM, Herrero Martín S, Entrena-Ureña L, Marcellini-Antonio S, Diaz-Jordan BL, Jurado-Herrera S, Pérez-González NF, García-Díaz C, García-Candel F, Fernández-Bello I, Mateo-Sotos J, Marco-Vera P +15 moredoaj PB2022: ELTROMBOPAG IN MYELODYSPLASTIC SYNDROME AND CHRONIC MYELOMONOCYTIC LEUKEMIA: A SINGLE-CENTER EXPERIENCE
HemaSphere, 2023 Amaia Lopez Peña, Marta Sofia Ordas Miguelez, Carmen Rodriguez Lefler, Pablo Estuardo Lopez Gomez, Mar Herrero Gutierrez, Laura Fernandez Cuezva, Jhossyuriel Obregon Membreño, Rita Gonzalez Resina, Laura Villarroya Martínez, Leire Etxebarria Bahillo, Rafael Monleon Gil, Ana Cristina Godoy Molias, Miguel Diaz Morfa, Isabel Izquierdo Garcia, Pilar Delgado Beltran, Gonzalo Caballero Navarro +15 moredoaj +1 more sourceAutomation in Blood Banking and Hemotherapy
Clinics in Laboratory Medicine, 1988 In summary, although instrumentation related to blood bank and transfusion medicine is not new, it is not yet widely available in smaller blood collection facilities and hospitals. Advances in technology with microplate processing and the changes in resources available for the blood bank, such as the technologist shortage, have led to development of ...openaire +2 more sourcesHemotherapy in Cardiac Surgery
, 2012 Demands for allogeneic blood transfusion in cardiac surgery were still high two decades ago. Today there is a gradual decline in transfusion requirements owing to recent advances in cardiac surgery and related specialties that have together developed techniques for perioperative blood salvage and its autotransfusion; this trend continues to progress ...openaire +2 more sourcesCaplacizumab treatment in elderly patients with iTTP: Experience from the Spanish TTP Registry
HemaSphereImmune thrombotic thrombocytopenic purpura (iTTP) typically affects middle‐aged individuals, although it sometimes appears in older patients. Caplacizumab is approved for the treatment of iTTP, but information on the safety and efficacy of this drug in ...Inés Gómez‐Seguí, Joan Cid, Miquel Lozano, Maria Eva Mingot‐Castellano, Cristina Pascual‐Izquierdo, Luz Maria Gonzalez del Castillo, Julia Maria Vidan Estevez, Faustino Garcia‐Candel, Moraima Jiménez Balarezo, David Valcarcel, Clara Cuellar Perez‐Avila, Maria Arraiz Ramirez, Sunil Lakhwani, Maria Gemma Moreno Jimenez, Ana Yurena Oliva Hernandez, Jose Maria Garcia Gala, Jorge Martinez Nieto, Rosa Goterris, Marta Fernández Docampo, Clara Sopeña Pell‐Ilderton, Javier de laRubia +20 moredoaj +1 more sourcePB2340: INFLUENCE OF INITIAL CLINICAL FEATURES IN THERAPEUTIC DECISIONS AND DIAGNOSTIC PROCESS OF ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA. A REAL WORLD EXPERIENCE
HemaSphere, 2022 L. Bolea, C. Jimenez, K. Velazquez, J. Marquet, M. Piris, F. Martin, P. Palomo, B. De Felipe, L. Perez, B. Astibia, C. Nuñez-Torron, J. Lopez, P. Herrera +12 moredoaj +1 more source